FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

14669111000001106: Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
50826001000001112 Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
50826101000001113 Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Is a Disopyramide 250mg m/r tablet false Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Has active ingredient Disopyramide phosphate false Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Has active ingredient Disopyramide true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Is a Rythmodan Retard true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Disopyramide true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Has specific active ingredient Disopyramide phosphate true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Has basis of strength substance Disopyramide true Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Is a Disopyramide 250mg modified-release tablets false Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Is a Disopyramide 250mg modified-release tablets true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) 40 tablet Is pack of False Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier
Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) 40 tablet Has AMP True Rythmodan Retard 250mg tablets (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start